MRVL Marvell Technology, Inc. Insider Trading

Marvell's President and COO Chris Koopmans sold 10,000 shares at $205.87 under pre-arranged 10b5-1 plan; still holds 237,392 shares post-transaction.

Chris Koopmans sold 10,000 shares (10.0K shares) for $2,058,700.00 ($2.1M) on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted 2026-01-05, reducing his holdings from 247,392 shares (247.4K shares) to 237,392 shares (237.4K shares). Because the transaction is scheduled under a 10b5-1 plan rather than discretionary, it does not reflect a timed market decision. His prior sales at MRVL show varying outcomes: the most recent sale on 2026-05-01 saw the stock rise +26.0% over 90 days, while an earlier sale on 2026-04-06 was followed by +86.0% gains over 90 days, but a 2025-02-18 sale preceded a -41.2% decline over the same period. The company reported net income of $1,901,300,000.00 ($1.9B) on revenue of $2,074,500,000.00 ($2.1B) in the latest quarter, with annual revenue growth of +42.1%, yet trades at a P/E of 31.80 relative to a $191,847,649,000.00 ($191.8B) market cap.

MRVL CFO Meintjes sells 4,000 shares at $175.24 under pre-arranged 10b5-1 plan; retains 226,675 shares post-transaction.

Meintjes Willem A, CFO of Marvell Technology, executed a sale of 4,000 shares at $175.24 on 2026-05-15 under a 10b5-1 trading plan adopted on 2026-01-09, reducing holdings from 230,675 shares to 226,675 shares. The transaction is scheduled and non-discretionary per the trading plan structure. The current stock price of $167.27 is -13.0% from the 52-week high of $192.15, though the stock has risen +19.7% over the prior 30 days and +111.7% over the prior 90 days. The sale occurs within the context of strong recent equity performance and solid fundamentals showing annual revenue growth of +42.1% and a P/E of 24.24.

CEO Murphy sells 7,500 MRVL shares for $1.3M via pre-arranged 10b5-1 plan; stock +37.1% in 30 days

Matthew J Murphy, Chairman and CEO of Marvell Technology, sold 7,500 shares at $177.26 on 2026-05-13 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-16, meaning this sale was scheduled and not driven by discretionary conviction. The stock has appreciated significantly since the sale date, rising to $183.52 (current price), with notable 30-day (+37.1%) and 90-day (+133.5%) gains. While Murphy retains substantial holdings of 739,397 shares post-transaction, his historical sell pattern is noteworthy: prior 13 sells averaged a 90-day return of +21.1% after the sales occurred, indicating the stock typically continued climbing after his exits—a pattern suggesting his prior sells were poorly timed. The underlying business fundamentals remain strong with annual revenue growth of +42.1% and net income of $1,901,300,000 against revenue of $2,074,500,000, though the elevated P/E of 26.60 reflects current market optimism.

Marvell COO Koopmans sold 10.0K shares at $162.76; 10b5-1 plan, stock now +37.1% in 30d

Chris Koopmans, President and COO of Marvell Technology, executed a 10,000-share sale on 2026-05-01 at $162.76, part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-05, meaning the transaction was scheduled and not driven by current discretionary conviction. The current stock price of $183.52 reflects a +37.1% 30-day and +133.5% 90-day gain, substantially outpacing the sale price, which signals the market has re-rated MRVL positively since the plan was established. Koopmans' prior sell timing record shows a 50% well-timed rate, and while this particular sale occurred before recent momentum, the underlying fundamentals—revenue of $2,074,500,000 with 42.1% annual growth and net income of $1,901,300,000—support the strong performance. The scheduled nature of this disposition under 10b5-1 precludes interpreting it as an insider capitulation signal, though it may reflect rebalancing or liquidity needs rather than confidence in current valuations.